Correction to: Design considerations of an IL13Rα2 antibody-drug conjugate for difuse intrinsic pontine glioma
- PMID: 34172087
- PMCID: PMC8235579
- DOI: 10.1186/s40478-021-01210-w
Correction to: Design considerations of an IL13Rα2 antibody-drug conjugate for difuse intrinsic pontine glioma
Erratum for
-
Design considerations of an IL13Rα2 antibody-drug conjugate for diffuse intrinsic pontine glioma.Acta Neuropathol Commun. 2021 May 17;9(1):88. doi: 10.1186/s40478-021-01184-9. Acta Neuropathol Commun. 2021. PMID: 34001278 Free PMC article.
Similar articles
-
A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors.Sci Rep. 2015 Dec 14;5:18133. doi: 10.1038/srep18133. Sci Rep. 2015. PMID: 26656559 Free PMC article.
-
Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.Lancet Oncol. 2018 Aug;19(8):1040-1050. doi: 10.1016/S1470-2045(18)30322-X. Epub 2018 Jun 18. Lancet Oncol. 2018. PMID: 29914796 Free PMC article. Clinical Trial.
-
Diffusion tensor imaging suggests extrapontine extension of pediatric diffuse intrinsic pontine gliomas.Eur J Radiol. 2016 Apr;85(4):700-6. doi: 10.1016/j.ejrad.2016.02.004. Epub 2016 Feb 4. Eur J Radiol. 2016. PMID: 26971411 Free PMC article.
-
Diffuse Intrinsic Pontine Glioma: Time for Cautious Optimism.J Child Neurol. 2016 Oct;31(12):1377-85. doi: 10.1177/0883073815601495. Epub 2015 Sep 14. J Child Neurol. 2016. PMID: 26374787 Free PMC article. Review.
-
Oncohistone Mutations in Diffuse Intrinsic Pontine Glioma.Trends Cancer. 2019 Dec;5(12):799-808. doi: 10.1016/j.trecan.2019.10.009. Epub 2019 Nov 9. Trends Cancer. 2019. PMID: 31813457 Free PMC article. Review.
References
Publication types
LinkOut - more resources
Full Text Sources